关键词: Psoriasis arthritis biologics guidelines psoriatic systemic treatment

Mesh : Antirheumatic Agents / administration & dosage therapeutic use Arthritis, Psoriatic / drug therapy physiopathology Biological Products / administration & dosage therapeutic use Biosimilar Pharmaceuticals / administration & dosage therapeutic use Dermatologic Agents / administration & dosage therapeutic use Humans Practice Guidelines as Topic Psoriasis / drug therapy physiopathology

来  源:   DOI:10.1080/17512433.2018.1548277   PDF(Sci-hub)

Abstract:
BACKGROUND: Psoriasis is a common chronic skin condition that is prevalent worldwide. Despite the numerous treatment options available, discrepancies exist between international guidelines. Areas covered: This review aims to evaluate the current international guidelines for the systemic treatment of psoriasis and psoriatic arthritis. Expert commentary: Most guidelines are unanimous on medication dosing and laboratory monitoring. However, even the most up-to-date guidelines do not include many of the new biologic medications. Guidelines will require frequent updates to include the newer treatments and will soon need to state a recommendation on the use of biosimilars.
摘要:
背景:银屑病是一种常见的慢性皮肤病,在全球范围内普遍存在。尽管有许多治疗选择,国际准则之间存在差异。涵盖的领域:这篇综述旨在评估当前国际上银屑病和银屑病关节炎的全身治疗指南。专家评论:大多数指南在用药剂量和实验室监测方面是一致的。然而,即使是最新的指南也不包括许多新的生物药物.指南将要求经常更新,以包括更新的治疗方法,并且很快需要就使用生物仿制药提出建议。
公众号